Enduring Activity: 2022 Updates in Clinical Oncology: “Gastrointestinal Cancers”
Evaluation and Credit: [ Ссылка ]
Target Audience
This activity is targeted toward physicians, physicians assistants, nurse practitioners, pharmacists, nurses and other health care providers in the practice specialties of family medicine, obstetrics/gynecology, internal medicine, neurology, oncology (and subspecialties), pathology, preventive medicine, radiology and surgery.
Statement of Need
This symposium has been designed to meet the educational needs of healthcare providers by presenting advancements and guidelines for improved patient care in clinical oncology. This program will address all primary areas of clinical oncology. Providers in the field have compiled the most salient practice-shifting information from abstracts and podium presentations, including surgical, medical, diagnostic, preventive and therapeutic clinical knowledge.
Objectives
1) Identify state-of-the-art care for cancer patients based on interdisciplinary tumor board consensus.
2) Discuss the integration of clinical trials as standard of care for cancer patients.
3) Describe standard therapeutic practices and the application of the newest therapies in the treatment of cancer patients.
Faculty
Basel M. Altoos, M.D.
Radiation Oncologist
Norton Cancer Institute
Ryan K. Jones, M.D.
Colorectal Surgeon
Norton Surgical Specialists
Douglas A. Nelson, M.D.
Hematology Oncologist
Norton Cancer Institute
Norton Healthcare
Louisville, KY
Faculty Disclosure
The faculty for this lecture have disclosed the following information. All conflicts of interest have been successfully mitigated prior the recording of this lecture.
Basel M. Altoos, M.D. – Has no relevant conflicts of interest to disclose.
Ryan K. Jones, M.D. – Discloses a relationship with Medtronic (speaker’s bureau).
Douglas A. Nelson, M.D. – Discloses a relationship as a stock holder with Bristol Myers Squibb, Invitae, Mirati Therapeutics, Myriad, Natera and Zymeworks.
Planner Disclosure
The planners of this activity have no relevant conflicts of interest to disclose.
The planners for this activity include the course director, Aaron C. Spalding, M.D., Ph.D.; and the planning committee members, Karen Busse, M.S., CCMEC; Pamela Jacobs, MHA, BSN, RN., CRNI, OCN; Sandra Stroud, B.A., CCMEC; Sally Sturgeon, DNP, R.N., SANE-A, AFN-BC; and Lauren White, CAP-OM
Physician Credits
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education
Designation
Norton Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Original Release | November 2022
Course Termination Date | November 2023
Contact Information | Center for Continuing Provider, Medical and Nursing Education cme@nortonhealthcare.org
